Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2393471
Max Phase: Preclinical
Molecular Formula: C27H27N3O5S
Molecular Weight: 505.60
Molecule Type: Small molecule
Associated Items:
ID: ALA2393471
Max Phase: Preclinical
Molecular Formula: C27H27N3O5S
Molecular Weight: 505.60
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)/C(CC(=O)c1cccc2c1C(=O)c1ccccc1C2=O)=N\NC(=S)NC1CCCCC1
Standard InChI: InChI=1S/C27H27N3O5S/c1-2-35-26(34)21(29-30-27(36)28-16-9-4-3-5-10-16)15-22(31)19-13-8-14-20-23(19)25(33)18-12-7-6-11-17(18)24(20)32/h6-8,11-14,16H,2-5,9-10,15H2,1H3,(H2,28,30,36)/b29-21-
Standard InChI Key: NSDKPXATDPPDEJ-ANYBSYGZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 505.60 | Molecular Weight (Monoisotopic): 505.1671 | AlogP: 3.75 | #Rotatable Bonds: 7 |
Polar Surface Area: 113.93 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.17 | CX Basic pKa: | CX LogP: 5.40 | CX LogD: 5.40 |
Aromatic Rings: 2 | Heavy Atoms: 36 | QED Weighted: 0.16 | Np Likeness Score: -0.39 |
1. Marković V, Janićijević A, Stanojković T, Kolundžija B, Sladić D, Vujčić M, Janović B, Joksović L, Djurdjević PT, Todorović N, Trifunović S, Joksović MD.. (2013) Synthesis, cytotoxic activity and DNA-interaction studies of novel anthraquinone-thiosemicarbazones with tautomerizable methylene group., 64 [PMID:23644206] [10.1016/j.ejmech.2013.03.071] |
Source(1):